293 related articles for article (PubMed ID: 10179873)
1. Regulations for in vivo radiopharmaceuticals used for diagnosis and monitoring--FDA. Proposed rule.
Fed Regist; 1998 May; 63(99):28301-9. PubMed ID: 10179873
[TBL] [Abstract][Full Text] [Related]
2. Regulations for in vivo radiopharmaceuticals used for diagnosis and monitoring; extension of comment period--FDA. Proposed rule; extension of comment period.
Fed Regist; 1998 Aug; 63(148):41219-20. PubMed ID: 10181522
[TBL] [Abstract][Full Text] [Related]
3. Regulations for in vivo radiopharmaceuticals used for diagnosis and monitoring. Food and Drug Administration, HHS. Final rule.
Fed Regist; 1999 May; 64(94):26657-70. PubMed ID: 10558516
[TBL] [Abstract][Full Text] [Related]
4. Revocation of regulation on positron emission tomography drug products--FDA. Final rule; revocation.
Fed Regist; 1997 Dec; 62(244):66522. PubMed ID: 10179303
[TBL] [Abstract][Full Text] [Related]
5. Removal of regulations regarding certification of antibiotic drugs; companion document to direct final rule--FDA. Proposed rule.
Fed Regist; 1998 May; 63(91):26127-9. PubMed ID: 10179335
[TBL] [Abstract][Full Text] [Related]
6. Removal of regulations regarding certification of drugs composed wholly or partly of insulin; companion document to direct final rule--FDA. Proposed rule.
Fed Regist; 1998 May; 63(92):26690-3. PubMed ID: 10179340
[TBL] [Abstract][Full Text] [Related]
7. Removal of regulations regarding certification of antibiotic drugs--FDA. Direct final rule.
Fed Regist; 1998 May; 63(91):26066-9. PubMed ID: 10179333
[TBL] [Abstract][Full Text] [Related]
8. List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness--FDA. Proposed rule.
Fed Regist; 1998 Oct; 63(195):54082-9. PubMed ID: 10185826
[TBL] [Abstract][Full Text] [Related]
9. Medical devices; humanitarian use of devices; companion to direct final rule--FDA. Proposed rule.
Fed Regist; 1998 Apr; 63(74):19196-200. PubMed ID: 10178431
[TBL] [Abstract][Full Text] [Related]
10. Removal of regulations regarding certification of drugs composed wholly or partly of insulin--FDA. Direct final rule.
Fed Regist; 1998 May; 63(92):26694-9. PubMed ID: 10179341
[TBL] [Abstract][Full Text] [Related]
11. Medical devices; reports of corrections and removals; companion to direct final rule--FDA. Proposed rule.
Fed Regist; 1998 Aug; 63(152):42300-4. PubMed ID: 10181727
[TBL] [Abstract][Full Text] [Related]
12. Investigational new drug applications; clinical holds; companion document to direct final rule--FDA. Proposed rule.
Fed Regist; 1998 Dec; 63(239):68710-2. PubMed ID: 10187560
[TBL] [Abstract][Full Text] [Related]
13. Draft guidance for industry on developing medical imaging drugs and biologics; availability--FDA. Availability of guidance.
Fed Regist; 1998 Oct; 63(198):55067-9. PubMed ID: 10185833
[TBL] [Abstract][Full Text] [Related]
14. Biological products regulated under Section 351 of the Public Health Services Act; implementation of biologics license; elimination of establishment license and product license--FDA. Proposed rule.
Fed Regist; 1998 Jul; 63(147):40858-71. PubMed ID: 10181717
[TBL] [Abstract][Full Text] [Related]
15. Medical devices; establishment registration and device listing for manufacturers and distributors of devices; companion to direct final rule--FDA. Proposed rule.
Fed Regist; 1998 Sep; 63(188):51874-5. PubMed ID: 10185813
[TBL] [Abstract][Full Text] [Related]
16. List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness. Food and Drug Administration, HHS. Final rule.
Fed Regist; 1999 Mar; 64(44):10944-7. PubMed ID: 10557618
[TBL] [Abstract][Full Text] [Related]
17. Dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices--FDA. Proposed rule.
Fed Regist; 1998 Jun; 63(109):31143-61. PubMed ID: 10180130
[TBL] [Abstract][Full Text] [Related]
18. Medical devices; exemption from premarket notification and reserved devices; Class I--FDA. Proposed rule.
Fed Regist; 1998 Nov; 63(218):63222-53. PubMed ID: 10187398
[TBL] [Abstract][Full Text] [Related]
19. New drug, antibiotic, and biological drug product regulations; accelerated approval--FDA. Final rule.
Fed Regist; 1992 Dec; 57(239):58942-60. PubMed ID: 10123232
[TBL] [Abstract][Full Text] [Related]
20. Medical devices; 30-day notices and 135-day PMA supplement review--FDA. Direct final rule; withdrawal.
Fed Regist; 1998 Aug; 63(154):42699. PubMed ID: 10182563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
